Actrapid and Cellcept drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actrapid (insulin) and Cellcept (mycophenolate mofetil). Common drug interactions include pleural effusion among females and diabetes mellitus among males.

The phase IV clinical study analyzes what interactions people have when they take Actrapid and Cellcept. It is created by eHealthMe based on reports of 58 people who take the same drugs from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.



On Jul, 13, 2026

58 people who take Actrapid and Cellcept together, and have interactions are studied.

Actrapid and Cellcept drug interactions.

What are the common drug interactions of Actrapid and Cellcept, by gender? *:

female:

  1. Pleural effusion (water on the lungs)
  2. Red blood cell count decreased
  3. Hypokalaemia (low potassium)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Proteinuria (presence of protein in the urine)
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Sclerosing encapsulating peritonitis (thick peritoneal membranes)
  8. Secondary hyperthyroidism
  9. Serum ferritin increased
  10. Transplant failure (transplantation failed to meet outcome)

male:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Anaemia (lack of blood)
  3. Gastric varices
  4. Hyperthyroidism (over activity of the thyroid gland)
  5. Intervertebral disc degeneration (spinal disc degeneration)
  6. Meniere's disease (a disorder of the inner ear that can affect hearing and balance to a varying degree)
  7. Muscle spasms (muscle contraction)
  8. Muscle twitching
  9. Obesity (having too much body fat)
  10. Osteoporosis (bones weak and more likely to break)

What are the common drug interactions of Actrapid and Cellcept, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Transplant rejection (a transplant material is not worked)
  2. Immunosuppressant drug level
  3. Low cardiac output syndrome (decreased cardiac output)
  4. Renal failure (kidney dysfunction)

20-29:

n/a

30-39:

  1. Anaemia (lack of blood)
  2. C-reactive protein increased
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Ileus (a painful obstruction of the ileum or other part of the intestine)
  5. Proteinuria (presence of protein in the urine)
  6. Sclerosing encapsulating peritonitis (thick peritoneal membranes)
  7. Secondary hyperthyroidism
  8. Serum ferritin increased
  9. Urinary incontinence (inability to control the flow of urine and involuntary urination)

40-49:

  1. Chest pain
  2. Death
  3. Peripheral swelling
  4. Skin lesion
  5. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

50-59:

  1. Haemorrhagic anaemia (anaemia due to excessive bleeding)
  2. Hepatotoxicity (chemical-driven liver damage)
  3. Hypertension (high blood pressure)
  4. Meningitis enterococcal (fungal inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  5. Staphylococcal bacteraemia (a bacterial infection of blood)
  6. Transplant failure (transplantation failed to meet outcome)
  7. Renal impairment (severely reduced kidney function)
  8. Anaemia (lack of blood)
  9. Dyspnoea (difficult or laboured respiration)
  10. General physical health deterioration (weak health status)

60+:

  1. General physical health deterioration (weak health status)
  2. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  3. Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Sedation
  6. Death
  7. Dehydration (dryness resulting from the removal of water)
  8. Urinary tract infection
  9. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  10. Blood creatine increased

What are the existing conditions these people have? *

  1. Diabetes: 6 people, 10.34%
  2. High Blood Pressure: 5 people, 8.62%
  3. Agitation (state of anxiety or nervous excitement): 5 people, 8.62%
  4. Malignant Melanoma (skin cancer rises from melancytes): 4 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and Cellcept?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Actrapid and Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actrapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin and mycophenolate mofetil (the active ingredients of Actrapid and Cellcept, respectively), and Actrapid and Cellcept (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: